In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV, and HCV), performed on the Tigris testing platform, to the newer Ultrio Elite triplex assay, and performed on the Panther testing platform. The CTS Phoenix lab will implement first on July 7th, with the 4 remaining CTS labs located in Charlotte, Dallas, St. Louis amd Tampa all implementing on July 13, 2020.
Click here for all the details: Communications
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....